Substance | Condition | Seq | Src | PMID | Dtl | Title |
Fucoidan | Acute Lung Injury | 1 | PM | 33313246 | 📋 | Fucoidan attenuates hyperoxia-induced lung injury in newborn rats by mediating lung fibroblasts differentiate into myofibroblasts |
Fucoidan | Acute Lung Injury | 2 | PM | 32533502 | 📋 | Fucoidan inhibits LPS-induced acute lung injury in mice through regulating GSK-3β-Nrf2 signaling pathway |
Fucoidan | Allergic Asthma | 1 | PM | 30651758 | 📋 | Oligo-fucoidan improved unbalance the Th1/Th2 and Treg/Th17 ratios in asthmatic patients: An ex vivo study |
Fucoidan | Anaphylaxis | 1 | PM | 32050429 | 📋 | Oral Administration of Fucoidan Can Exert Anti-Allergic Activity after Allergen Sensitization by Enhancement of Galectin-9 Secretion in Blood |
Fucoidan | Asthma | 1 | PM | 32580518 | 📋 | The Role of Fucoidans Isolated from the Sporophylls of Undaria pinnatifida against Particulate-Matter-Induced Allergic Airway Inflammation: Evidence of the Attenuation of Oxidative Stress and Inflammatory Responses |
Fucoidan | Bronchopulmonary Dysplasia | 1 | PM | 33313246 | 📋 | Fucoidan attenuates hyperoxia-induced lung injury in newborn rats by mediating lung fibroblasts differentiate into myofibroblasts |
Fucoidan | Hyperoxia | 1 | PM | 33313246 | 📋 | Fucoidan attenuates hyperoxia-induced lung injury in newborn rats by mediating lung fibroblasts differentiate into myofibroblasts |
Fucoidan | Hyperoxia | 2 | PM | 29138816 | 📋 | Protective effects of fucoidan against hyperoxic lung injury via the ERK signaling pathway |
Fucoidan | Hypoxia | 1 | PM | 26047481 | 📋 | Fucoidan Suppresses Hypoxia-Induced Lymphangiogenesis and Lymphatic Metastasis in Mouse Hepatocarcinoma |
Fucoidan | Hypoxia | 2 | PM | 25874385 | 📋 | Cardioprotective effects of fucoidan against hypoxia-induced apoptosis in H9c2 cardiomyoblast cells |
Fucoidan | Lung Cancer | 16 | PM | 37780215 | 📋 | Antimetastatic effect of fucoidan against non-small cell lung cancer by suppressing non-receptor tyrosine kinase and extracellular signal-related kinase pathway |
Fucoidan | Lung Cancer | 15 | PM | 36967501 | 📋 | Fucoidan enhances the effect of chemotherapeutic drug against drug-resistant lung cancer cells |
Fucoidan | Lung Cancer | 13 | PM | 35299642 | 📋 | A Transcriptome Sequencing Study on Genome-Wide Gene Expression Differences of Lung Cancer Cells Modulated by Fucoidan |
Fucoidan | Lung Cancer | 12 | PM | 34590105 | 📋 | Comparative study on the mechanisms of anti-lung cancer activities of three sulfated galactofucans |
Fucoidan | Lung Cancer | 14 | PM | 34502035 | 📋 | Enhancement of Immune Checkpoint Inhibitor-Mediated Anti-Cancer Immunity by Intranasal Treatment of Ecklonia cava Fucoidan against Metastatic Lung Cancer |
Fucoidan | Lung Cancer | 10 | PM | 33921340 | 📋 | Effect of Oversulfation on the Composition, Structure, and In Vitro Anti-Lung Cancer Activity of Fucoidans Extracted from Sargassum aquifolium |
Fucoidan | Lung Cancer | 11 | PM | 33430854 | 📋 | Antitumor effect and molecular mechanism of fucoidan in NSCLC |
Fucoidan | Lung Cancer | 7 | PM | 32169452 | 📋 | Fucoidan increased the sensitivity to gefitinib in lung cancer cells correlates with reduction of TGFβ-mediated Slug expression |
Fucoidan | Lung Cancer | 9 | PM | 29746926 | 📋 | Fucoidan upregulates TLR4/CHOP-mediated caspase-3 and PARP activation to enhance cisplatin-induced cytotoxicity in human lung cancer cells |
Fucoidan | Lung Cancer | 3 | PM | 28332554 | 📋 | Fucoidan induces Toll-like receptor 4-regulated reactive oxygen species and promotes endoplasmic reticulum stress-mediated apoptosis in lung cancer |
Fucoidan | Lung Cancer | 2 | PM | 27569654 | 📋 | Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling |
Fucoidan | Lung Cancer | 8 | PM | 25451746 | 📋 | In vitro anticancer activity of fucoidan from Turbinaria conoides against A549 cell lines |
Fucoidan | Lung Cancer | 1 | PM | 25149540 | 📋 | Fucoidan inhibition of lung cancer in vivo and in vitro : role of the Smurf2-dependent ubiquitin proteasome pathway in TGFβ receptor degradation |
Fucoidan | Lung Cancer | 5 | PM | 23226337 | 📋 | Fucoidan from seaweed Fucus vesiculosus inhibits migration and invasion of human lung cancer cell via PI3K-Akt-mTOR pathways |
Fucoidan | Lung Cancer | 4 | PM | 21624396 | 📋 | Fucoidan from Sargassum sp. and Fucus vesiculosus reduces cell viability of lung carcinoma and melanoma cells in vitro and activates natural killer cells in mice in vivo |
Fucoidan | Lung Cancer | 6 | PM | 21452391 | 📋 | Fucoidan from Undaria pinnatifida induces apoptosis in A549 human lung carcinoma cells |
Fucoidan | Lung Inflammation | 1 | PM | 33374149 | 📋 | Fucoidan and Lung Function: Value in Viral Infection |
Fucoidan | Lung Inflammation | 2 | PM | 32397317 | 📋 | Oral Fucoidan Attenuates Lung Pathology and Clinical Signs in a Severe Influenza a Mouse Model |
Fucoidan | Lung Injury | 2 | PM | 33374149 | 📋 | Fucoidan and Lung Function: Value in Viral Infection |
Fucoidan | Lung Injury | 1 | PM | 29138816 | 📋 | Protective effects of fucoidan against hyperoxic lung injury via the ERK signaling pathway |
Fucoidan | Oral Cancer | 6 | PM | 37648299 | 📋 | Fucoidan Enhances Cisplatin-induced Effects on SCC-25 Human Oral Cancer Cells by Inhibiting the PI3K/AKT Pathway |
Fucoidan | Oral Cancer | 5 | PM | 36139871 | 📋 | Fucoidan/UVC Combined Treatment Exerts Preferential Antiproliferation in Oral Cancer Cells but Not Normal Cells |
Fucoidan | Oral Cancer | 4 | PM | 35624705 | 📋 | Brown Algae-Derived Fucoidan Exerts Oxidative Stress-Dependent Antiproliferation on Oral Cancer Cells |
Fucoidan | Oral Cancer | 3 | PM | 32856880 | 📋 | Antitumor Effects of Fucoidan Via Apoptotic and Autophagic Induction on HSC-3 Oral Squamous CellCarcinoma |
Fucoidan | Oral Cancer | 1 | PM | 31495936 | 📋 | Fucoidan affects oral squamous cell carcinoma cell functions in vitro by regulating FLNA-derived circular RNA |
Fucoidan | Oral Cancer | 2 | PM | 28004293 | 📋 | Fucoidan reduced the invasion of oral squamous cell carcinoma cells and modified their effects to macrophages |
Fucoidan | Oral Submucous Fibrosis | 1 | PM | 35890132 | 📋 | Fucoidan-Mediated Inhibition of Fibrotic Properties in Oral Submucous Fibrosis via the MEG3/miR-181a/Egr1 Axis |
Fucoidan | Pneumonia | 1 | PM | 30889882 | 📋 | Dietary Supplementation with Low-Molecular-Weight Fucoidan Enhances Innate and Adaptive Immune Responses and Protects against Mycoplasma pneumoniae Antigen Stimulation |
Fucoidan | Pulmonary Fibrosis | 5 | PM | 37298817 | 📋 | Isolation, Characterization, and Anti-Idiopathic Pulmonary Fibrosis Activity of a Fucoidan from Costaria costata |
Fucoidan | Pulmonary Fibrosis | 4 | PM | 35281460 | 📋 | Low Molecular Weight Fucoidan Inhibits Pulmonary Fibrosis In Vivo and In Vitro via Antioxidant Activity |
Fucoidan | Pulmonary Fibrosis | 3 | PM | 34560978 | 📋 | Low molecular weight fucoidan attenuating pulmonary fibrosis by relieving inflammatory reaction and progression of epithelial-mesenchymal transition |
Fucoidan | Pulmonary Fibrosis | 2 | PM | 31105865 | 📋 | Low-molecular-weight fucoidan attenuates bleomycin-induced pulmonary fibrosis: possible role in inhibiting TGF-β1-induced epithelial-mesenchymal transition through ERK pathway |
Fucoidan | Pulmonary Fibrosis | 1 | PM | 30347679 | 📋 | Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues |
Fucoidan | Pulmonary Hypertension | 1 | PM | 30557519 | 📋 | Evidence for the Fucoidan/P-Selectin Axis as a Therapeutic Target in Hypoxia-induced Pulmonary Hypertension |